J. Thomas

发表

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

A. Riddell, A. Wotherspoon, D. Cunningham, 2009, British Journal of Cancer.

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

A. Riddell, A. Wotherspoon, D. Cunningham, 2009, British Journal of Cancer.

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.

D. Tait, J. Tabernero, A. Wotherspoon, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.

D. Cunningham, G. Brown, I. Chau, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study.

D. Cunningham, G. Brown, I. Chau, 2014, European journal of cancer.

A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.

T. Hickish, A. Wotherspoon, D. Cunningham, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

The combination of a chemotherapy doublet (gemcitabine plus capecitabine) with a biologic doublet (bevacizumab plus erlotinib) in patients with advanced pancreatic adenocarcinoma: The TARGET study.

D. Cunningham, I. Chau, K. Thomas, 2010 .

A dose-escalation study of gemcitabine (Gem) plus oxaliplatin (Ox) in combination with imatinib in patients (pts) with gemcitabine-refractory advanced pancreatic adenocarcinoma (PC).

D. Cunningham, I. Chau, K. Thomas, 2010 .